Mineralys Therapeutics, Inc. (MLYS) PT Raised to $43 at BofA Securities
Tweet
Share
E-mailGet Alerts MLYS Hot Sheet
Price: $26.05 +1.60%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
BofA Securities analyst Tim Anderson raised the price target on Mineralys Therapeutics, Inc. (NASDAQ: MLYS) to $43.00 (from $38.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
- Samsonite International SA (1910:HK) (SMSEY) PT Lowered to HK$19.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
